أنتيروب كبسولات كليندامايسين لعلاج العدوى البكتيرية في الكلاب والقطط
Antirobe (clindamycin hydrochloride) is an oral lincosamide antibiotic capsule with outstanding tissue and bone penetration. Indicated in dogs and cats for the treatment of dental infections, osteomyelitis, deep soft tissue wounds, abscesses, and superficial/deep pyoderma caused by susceptible strains of Staphylococcus, Streptococcus, and anaerobic bacteria.
Dosage Form
Capsule
Product Type
Pharmaceutical
Manufacturer
Package
Bottles of 100 capsules (25 mg, 75 mg, 150 mg, and 300 mg clindamycin base)
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | 5.5 to 11 mg/kg (2.5 to 5.0 mg/lb) body weight orally every 12 hours for soft tissue and dental infections; 11 mg/kg every 12 hours for osteomyelitis | Oral capsule | Administer for 7 to 28 consecutive days; continue for at least 48 hours after signs resolve |
| Cat | 11 to 22 mg/kg (5.0 to 10.0 mg/lb) body weight orally every 24 hours | Oral capsule | Administer for 7 to 14 days |
No withdrawal information available.
Treatment of periodontal infections and dental disease in dogs caused by susceptible anaerobes.
Treatment of osteomyelitis caused by Staphylococcus aureus in dogs.
Treatment of wounds, abscesses, and pyoderma in dogs and cats caused by susceptible Gram-positive and anaerobic pathogens.
Do not use in animals known to be hypersensitive to clindamycin or lincomycin.
Not for use in rabbits, guinea pigs, chinchillas, or horses.
Use with caution in animals with severe renal or hepatic disease.
Vomiting, loose stools, or transient anorexia.
Antirobe (clindamycin hydrochloride) Prescribing Information
Leaflet150 mg/capsule (as hydrochloride)
No diseases linked.
No data available
Information has not been added yet.
Manufacturer
No alternatives available.